News Releases

Dec 12, 2008
OncoMed Pharmaceuticals Expands Series B Financing with Addition of Delphi Ventures and Names Deepa Pakianathan, Ph.D., to Board of Directors
OncoMed Pharmaceuticals Expands Series B Financing with Addition of Delphi Ventures and Names Deepa Pakianathan, Ph.D., to Board of DirectorsDownload File

OncoMed Pharmaceuticals, Inc. is a wholly-owned subsidiary of Mereo BioPharma Group plc.
Please visit our parent site www.mereobiopharma.com for our Pipeline, Partnering Opportunities and Investors information.